Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists. [electronic resource]
Producer: 20110907Description: 270-80 p. digitalISSN:- 1873-3735
- Animals
- Anti-Obesity Agents -- adverse effects
- Genetic Testing -- methods
- Humans
- Obesity -- drug therapy
- Piperidines -- adverse effects
- Polymorphism, Genetic
- Precision Medicine -- methods
- Pyrazoles -- adverse effects
- Receptor, Cannabinoid, CB1 -- antagonists & inhibitors
- Rimonabant
- Substance-Related Disorders -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.